Results 331 to 340 of about 527,379 (343)

Interleukin-22: Immunobiology and Pathology

Annual Review of Immunology, 2015
Jarrod A Dudakov, Alan Hanash, Marcel R M Van Den Brink   +2 more
exaly  

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

New England Journal of Medicine, 1987
W M Linehan
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Philip J Mease, Bruce W Kirkham, Arthur Kavanaugh   +2 more
exaly  

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Lancet, The, 2013
Antoinette Moran, Linda A Dimeglio, Carla J Greenbaum   +2 more
exaly  

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

New England Journal of Medicine, 2012
Claus Otto Carl Zachariae
exaly  

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
Geert D'Haens, Julian Panes, Arthur Kaser   +2 more
exaly  

Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock

Lancet, The, 2004
Ash A Alizadeh, Steven B Welch, Simon Nadel   +2 more
exaly  

Interleukin-1 and neuronal injury

Nature Reviews Immunology, 2005
Stuart Allan
exaly  

Signaling and Function of Interleukin-2 in T Lymphocytes

Annual Review of Immunology, 2018
Sarah H Ross, Doreen A Cantrell
exaly  

The Role of Interleukin-1 in Disease

New England Journal of Medicine, 1993
exaly